ILMN Illumina, Inc.

NASDAQ
$214.91

Illumina, Inc. (ILMN) is expected to report earnings on January 28, 2027, after the market close. The consensus earnings estimate is $1.52 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -16.0% since its last earnings release on October 29, 2026.

Illumina Missed Expectations, Raises Guidance
Thursday, October 29, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $1.52
Rev est $1.22B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $224.71

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Illumina, Inc.

Illumina Inc provides sequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 5 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.